<p>Clinical demographics of patients in the genotype–phenotype correlation study.</p
<p>Demographics and baseline labs of patients included in pharmacogenetic analyses (n = 35).</p
<p>Study cohort characteristics and relationships between patient age, INPC, stage and genomic profi...
<p>Demographic and clinical characteristics of the study population (study sample n = 20,759).</p
<p>Clinical parameters and the genotype of the patients involved in the study.</p
<p>Demographic and genotypic information for patients and healthy comparison subjects.</p
<p>Summary of 164 AHC patients included in the genotype-phenotype correlation study.</p
<p>Demographic and clinical characteristics of the patient groups under study.</p
Demographic and clinical characteristics of cohort of patients considered in the study.</p
<p>Demographic information and tumor characteristics of patients included in genotyping ancillary st...
<p>p-value <0.05 are considered statistically significant</p><p>Correlations between (TA)<sub>n</sub...
Demographic and Clinical characteristics of the patients included in the study (N = 337).</p
Demographic and clinical characteristics of patients whose samples were used in the study.</p
Demographics: Patient characteristics and clinical data for the corresponding groups.</p
Comparison of genotype associations with PCOS–current study versus. other reports.</p
<p>Demographic, Clinical, and Genetic Characteristics of the Initial Study Population.</p
<p>Demographics and baseline labs of patients included in pharmacogenetic analyses (n = 35).</p
<p>Study cohort characteristics and relationships between patient age, INPC, stage and genomic profi...
<p>Demographic and clinical characteristics of the study population (study sample n = 20,759).</p
<p>Clinical parameters and the genotype of the patients involved in the study.</p
<p>Demographic and genotypic information for patients and healthy comparison subjects.</p
<p>Summary of 164 AHC patients included in the genotype-phenotype correlation study.</p
<p>Demographic and clinical characteristics of the patient groups under study.</p
Demographic and clinical characteristics of cohort of patients considered in the study.</p
<p>Demographic information and tumor characteristics of patients included in genotyping ancillary st...
<p>p-value <0.05 are considered statistically significant</p><p>Correlations between (TA)<sub>n</sub...
Demographic and Clinical characteristics of the patients included in the study (N = 337).</p
Demographic and clinical characteristics of patients whose samples were used in the study.</p
Demographics: Patient characteristics and clinical data for the corresponding groups.</p
Comparison of genotype associations with PCOS–current study versus. other reports.</p
<p>Demographic, Clinical, and Genetic Characteristics of the Initial Study Population.</p
<p>Demographics and baseline labs of patients included in pharmacogenetic analyses (n = 35).</p
<p>Study cohort characteristics and relationships between patient age, INPC, stage and genomic profi...
<p>Demographic and clinical characteristics of the study population (study sample n = 20,759).</p